JP2004529924A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004529924A5 JP2004529924A5 JP2002581041A JP2002581041A JP2004529924A5 JP 2004529924 A5 JP2004529924 A5 JP 2004529924A5 JP 2002581041 A JP2002581041 A JP 2002581041A JP 2002581041 A JP2002581041 A JP 2002581041A JP 2004529924 A5 JP2004529924 A5 JP 2004529924A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- aromatase inhibitor
- composition according
- administered
- single dose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003886 aromatase inhibitor Substances 0.000 claims 86
- 239000008194 pharmaceutical composition Substances 0.000 claims 79
- 229940122815 Aromatase inhibitor Drugs 0.000 claims 74
- 102000012673 Follicle Stimulating Hormone Human genes 0.000 claims 25
- 108010079345 Follicle Stimulating Hormone Proteins 0.000 claims 25
- 229940028334 follicle stimulating hormone Drugs 0.000 claims 25
- 239000002552 dosage form Substances 0.000 claims 15
- 229940046844 aromatase inhibitors Drugs 0.000 claims 12
- 230000027758 ovulation cycle Effects 0.000 claims 11
- BFYIZQONLCFLEV-DAELLWKTSA-N Aromasine Chemical compound O=C1C=C[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC(=C)C2=C1 BFYIZQONLCFLEV-DAELLWKTSA-N 0.000 claims 8
- 229940011871 estrogen Drugs 0.000 claims 8
- 239000000262 estrogen Substances 0.000 claims 8
- 229960000255 exemestane Drugs 0.000 claims 8
- 229960002932 anastrozole Drugs 0.000 claims 7
- YBBLVLTVTVSKRW-UHFFFAOYSA-N anastrozole Chemical compound N#CC(C)(C)C1=CC(C(C)(C#N)C)=CC(CN2N=CN=C2)=C1 YBBLVLTVTVSKRW-UHFFFAOYSA-N 0.000 claims 7
- 208000000509 infertility Diseases 0.000 claims 6
- 230000036512 infertility Effects 0.000 claims 6
- 231100000535 infertility Toxicity 0.000 claims 6
- 238000003018 immunoassay Methods 0.000 claims 4
- 229960003881 letrozole Drugs 0.000 claims 4
- HPJKCIUCZWXJDR-UHFFFAOYSA-N letrozole Chemical group C1=CC(C#N)=CC=C1C(N1N=CN=C1)C1=CC=C(C#N)C=C1 HPJKCIUCZWXJDR-UHFFFAOYSA-N 0.000 claims 4
- 230000016087 ovulation Effects 0.000 claims 4
- 230000002441 reversible effect Effects 0.000 claims 4
- 230000003637 steroidlike Effects 0.000 claims 4
- 230000001939 inductive effect Effects 0.000 claims 3
- 230000002513 anti-ovulatory effect Effects 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 230000000624 ovulatory effect Effects 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28428201P | 2001-04-17 | 2001-04-17 | |
| PCT/CA2002/000527 WO2002083241A1 (en) | 2001-04-17 | 2002-04-17 | Single dose aromatase inhibitor for treating infertility |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004529924A JP2004529924A (ja) | 2004-09-30 |
| JP2004529924A5 true JP2004529924A5 (enExample) | 2006-01-05 |
Family
ID=23089583
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002581041A Pending JP2004529924A (ja) | 2001-04-17 | 2002-04-17 | 不妊症治療ための単回投与アロマターゼ阻害薬 |
Country Status (32)
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2491372A1 (en) * | 2002-07-02 | 2004-01-15 | Pharmacia & Upjohn Company Llc | Infertility treatment with exemestane |
| WO2004087211A2 (en) | 2003-04-01 | 2004-10-14 | Applied Research Systems Ars Holding N.V. | Inhibitors of phosphodiesterases in infertility |
| CA2619503A1 (en) * | 2005-06-28 | 2007-01-04 | Robert F. Casper | Aromatase inhibitors for emergency contraception |
| CA2637000A1 (en) * | 2006-01-10 | 2007-07-19 | Diobex, Inc. | Methods and compositions for treating prostate cancer, benign prostatic hypertrophy, polycystic ovary syndrome and other conditions |
| WO2011143752A1 (en) * | 2010-05-20 | 2011-11-24 | University Of Saskatchewan | Use of aromatase inhibitors for synchronizing ovulation, inducing superovulation or double ovulation and improving twinning and fertility in a mammal |
| BR112015026298A8 (pt) | 2013-04-19 | 2019-12-24 | Univ Saskatchewan | veículo de dispensação para a dispensação de um inibidor da aromatase |
| US20160022644A1 (en) * | 2014-07-22 | 2016-01-28 | Tsu-I Catherine Wang | Oral Transmucosal Compositions Including Aromatase Inhibitors for Treating Female Infertility |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4728645A (en) * | 1982-12-21 | 1988-03-01 | Ciba-Geigy Corporation | Substituted imidazo[1,5-A]pyridine derivatives and other substituted bicyclic derivatives, useful as aromatase inhibitors |
| US4845227A (en) * | 1984-06-18 | 1989-07-04 | Eli Lilly And Company | Aromatase inhibitors from azoles |
| US4602025A (en) * | 1984-06-18 | 1986-07-22 | Eli Lilly And Company | Aromatase inhibitors |
| US4978672A (en) * | 1986-03-07 | 1990-12-18 | Ciba-Geigy Corporation | Alpha-heterocyclc substituted tolunitriles |
| GB8726505D0 (en) * | 1987-11-12 | 1987-12-16 | Ici Plc | Naphtho(2 1-b)furan derivatives |
| DE4330237C2 (de) | 1993-09-02 | 1995-11-30 | Schering Ag | 1-Methylsubstituierte Androsta-1,4-dien-3,17-dione, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate |
| CA2250908C (en) * | 1996-04-30 | 2012-03-13 | Takeda Chemical Industries, Ltd. | Combined use of gnrh agonist and antagonist |
| DE19622457A1 (de) | 1996-05-24 | 1997-11-27 | Schering Ag | 7alpha-(5-Methylaminopentyl)-estratriene, Verfahren zu deren Herstellung, pharmazeutische Präparate, die diese 7alpha-(5-Methylaminopentyl)-estratriene enthalten sowie deren Verwendung zur Herstellung von Arzneimitteln |
| US6953774B2 (en) * | 2000-08-11 | 2005-10-11 | Applied Research Systems Ars Holding N.V. | Methods of inducing ovulation |
-
2002
- 2002-04-17 WO PCT/CA2002/000527 patent/WO2002083241A1/en not_active Ceased
- 2002-04-17 EA EA200301128A patent/EA011310B1/ru not_active IP Right Cessation
- 2002-04-17 AR ARP020101399A patent/AR034036A1/es unknown
- 2002-04-17 NZ NZ552873A patent/NZ552873A/en not_active IP Right Cessation
- 2002-04-17 SK SK1424-2003A patent/SK14242003A3/sk unknown
- 2002-04-17 BR BR0208920-3A patent/BR0208920A/pt not_active IP Right Cessation
- 2002-04-17 KR KR10-2003-7013484A patent/KR20040025916A/ko not_active Ceased
- 2002-04-17 JP JP2002581041A patent/JP2004529924A/ja active Pending
- 2002-04-17 CA CA2444980A patent/CA2444980C/en not_active Expired - Fee Related
- 2002-04-17 PT PT02717919T patent/PT1383578E/pt unknown
- 2002-04-17 SI SI200230747T patent/SI1383578T1/sl unknown
- 2002-04-17 HR HR20030839A patent/HRP20030839A2/hr not_active Application Discontinuation
- 2002-04-17 UA UA20031110268A patent/UA82648C2/uk unknown
- 2002-04-17 AT AT02717919T patent/ATE409066T1/de active
- 2002-04-17 MX MXPA03009447A patent/MXPA03009447A/es not_active Application Discontinuation
- 2002-04-17 AU AU2002249043A patent/AU2002249043B2/en not_active Ceased
- 2002-04-17 EE EEP200300505A patent/EE200300505A/xx unknown
- 2002-04-17 HU HU0304003A patent/HUP0304003A2/hu unknown
- 2002-04-17 DK DK02717919T patent/DK1383578T3/da active
- 2002-04-17 PL PL02366744A patent/PL366744A1/xx not_active Application Discontinuation
- 2002-04-17 DE DE60229047T patent/DE60229047D1/de not_active Expired - Lifetime
- 2002-04-17 US US10/475,101 patent/US8008333B2/en not_active Expired - Fee Related
- 2002-04-17 ES ES02717919T patent/ES2311599T3/es not_active Expired - Lifetime
- 2002-04-17 YU YU81203A patent/YU81203A/sh unknown
- 2002-04-17 CN CNA028120825A patent/CN1551789A/zh active Pending
- 2002-04-17 EP EP02717919A patent/EP1383578B1/en not_active Expired - Lifetime
- 2002-04-17 IL IL15839602A patent/IL158396A0/xx unknown
- 2002-04-17 CZ CZ20033107A patent/CZ20033107A3/cs unknown
-
2003
- 2003-09-23 NO NO20034246A patent/NO20034246L/no not_active Application Discontinuation
- 2003-09-26 ZA ZA200307516A patent/ZA200307516B/en unknown
- 2003-11-07 BG BG108323A patent/BG108323A/bg unknown
-
2008
- 2008-12-12 CY CY20081101446T patent/CY1108648T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100248857B1 (ko) | 호르몬 대체치료 | |
| US8450299B2 (en) | Methods of hormonal treatment utilizing ascending-dose extended cycle regimens | |
| RU2245713C2 (ru) | Прерывистая гормонозаместительная терапия низкими дозами эстрогена | |
| AU2010201022C1 (en) | Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration | |
| JPH09169649A (ja) | 避妊のための多段階調剤 | |
| JP2005514345A (ja) | 更年期以降の女性生殖機能障害の治療のための組成物 | |
| Machado et al. | Bleeding patterns and menstrual-related symptoms with the continuous use of a contraceptive combination of ethinylestradiol and drospirenone: a randomized study | |
| AU2005294269B2 (en) | Methods of hormonal treatment utilizing ascending-dose extended cycle regimens | |
| JP2004529924A5 (enExample) | ||
| Haukkamaa et al. | Contraception with subdermal implants releasing the progestin ST-1435: a dose-finding study | |
| CA2444980A1 (en) | Single dose aromatase inhibitor for treating infertility | |
| CA2472309A1 (en) | Multiple dose aromatase inhibitor for treating infertility | |
| RU2181598C2 (ru) | Восстановление тонической секреции эстрогена из яичников для продолжительных схем лечения | |
| JP7149541B2 (ja) | 男性不妊症における精子所見を改善するための経口摂取用組成物 | |
| NO20072687L (no) | Farmasoytisk prevensjonspreparat | |
| Letassy et al. | Nafarelin acetate: a gonadotropin-releasing hormone agonist for the treatment of endometriosis | |
| Sanfilippo et al. | Influence of certain prostaglandin synthetase inhibitors on cytoplasmic estrogen receptors in the uterus | |
| Cohen | Anti-osteoporotic medications: traditional and nontraditional | |
| KR20080065651A (ko) | 경구용 피임제 형태로의 기능장애 자궁 출혈의 경구 치료를위한 디에노게스트와 조합된 에스트라디올 발러레이트또는 에스트라디올의 용도 | |
| US20100292150A1 (en) | Treatment of Menorrhagia with Aromatase Inhibitor | |
| AU2011203526A1 (en) | Methods of hormonal treatment utilizing ascending-dose extended cycle regimens |